Dr. Martens’ chief product officer Adam Meek is stepping down from his role after four years.
In a post to LinkedIn over the weekend, Meek announced the news. “I’m proud of the work we did to reconnect product to purpose and consumer, to strengthen the brand, and to bring fresh ideas to life at scale,” the footwear veteran wrote. “Most of all, I’m grateful and thankful for the brilliant people I had the chance to work with – and the many friendships formed along the way. The people at Docs are special.”
Meek joined Dr. Martens in 2021 from Canada Goose, where he served as general manager of footwear and accessories. Prior to Canada Goose, Meek held the role of global senior vice president of product at Sperry from 2016 to 2020. Over his career, he also served in high-level roles at Nike and Pentland Brands.
“Leading product [merchandising], design, development and innovation for such an iconic global brand – and working alongside incredibly talented teams across the world – has been a privilege,” Meek further wrote on LinkedIn. “Together we navigated complex change, sharpened brand clarity, evolved the product architecture and portfolio, and delivered new energy into the market which is exciting consumers around the world.”
When reached by FN, a Dr. Martens representative confirmed the news. “After four years at Dr. Martens, Adam has decided the time is right for him to move on and pursue the next step in his career,” the rep said. “He leaves with our thanks and appreciation for the exceptional product team and the collaborations he’s helped build across the industry.”
In its most recent earnings report released in January, Dr. Martens noted that its group revenue fell 3.1 percent on a reported basis in the third quarter of fiscal 2026 to 251 million pounds, with year-to-date revenue down 1.8 percent to 573 million pounds.
By channel, wholesale revenue was up 9.3 percent on a reported basis in Q3, with year-to-date revenue up 3.3 percent. As for DTC, revenue in Q3 dropped 7 percent on a reported basis, with year-to-date revenue down 4.6 percent.
Dr. Martens’ chief executive officer Ije Nwokorie said in a statement in January that fiscal 2026 is “a year of pivot,” as the company makes the “necessary changes” to its business to set it up for future sustainable growth.
“I remain laser focused on executing our new strategy and we will deliver all four of our strategic objectives for fiscal year 2026,” Nwokorie noted. “We have continued to improve the quality of our revenue through a disciplined approach to promotions and this represents a headwind to overall revenue, particularly in e-commerce.”
